HCD Economics exists to deliver strategic advice and support to address HTA and health economic evidence needs for market access, pricing and reimbursement across UK, other key European markets and the US.

This is achieved in collaboration with local and national health services, the pharmaceutical industry, and other organisations in order to inform and support healthcare decision-making.

HCD Economics was established as a multi-disciplinary team with expertise in health economics, modelling, statistics, health services research, and systematic reviews. The multi-disciplinary nature of the team at HCD allows an appropriate mix of skills to be applied to an array of health challenges. HCD’s status as an academic consultancy company with close links to other academic groups and NHS policy-makers ensures the credibility and influence of its work, both within academic and health service communities.